Related Experiment Video
Updated: May 20, 2025

10:05
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
Published on: September 16, 2015
14.3K
Reevaluating the brain disease model of addiction
Chrysanthi Blithikioti1, Eiko I Fried2, Emiliano Albanese3
1Department of General Psychology, University of Padova, Padova, Italy.
The Lancet. Psychiatry
|March 28, 2025
Summary
The dominant brain disease model of addiction lacks clear definition, hindering understanding and research. This analysis explores narrow and broad views of brain disease in addiction, proposing ways forward.
Area of Science:
- Psychiatry
- Neuroscience
- Philosophy of Medicine
Background:
- The brain disease model of addiction (substance use disorder [SUD]) has been prevalent for 30 years, viewed as a chronic relapsing condition.
- This model aimed to explain SUD etiology and reduce stigma, but faces criticism for weak empirical support and neglecting psychosocial factors.
Purpose of the Study:
- To critically examine the definition and application of the "brain disease" concept in addiction research.
- To analyze the implications of narrow and broad definitions of brain disease on understanding and treating SUDs.
- To propose a path forward for more productive debate and knowledge advancement in addiction.
Main Methods:
- Philosophical analysis of concepts in psychiatry.
- Review of theoretical assumptions and empirical evidence for different views of brain disease in addiction.
- Examination of treatment implications.
Main Results:
- The lack of a clear, consistent definition of "brain disease" obstructs productive discourse on addiction.
- Two main conceptualizations of brain disease exist: a "narrow view" requiring specific damage and a "broad view" considering all mental activity as brain-based.
- Both views are applied inconsistently in addiction research, impacting understanding and treatment.
Conclusions:
- Moving beyond the current debate requires a more precise and consistently applied definition of brain disease in the context of addiction.
- Addressing the conceptual ambiguity is crucial for advancing research and improving treatment strategies for substance use disorders.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
417
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
417
Substance Use Disorders Affecting Sleep
152
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
152
Attention-Deficit/Hyperactivity Disorder
34
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
34
Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399

